Health Union survey shows that, when compared to the more common forms of blood cancer, respondents living with myeloproliferative neoplasms (MPN) appear to have less traditional and, at times, more difficult treatment journeys.

Survey data shows people newly diagnosed with an autoimmune condition report being less active and less confident in their treatment decisions.